Thomas Biancardi
Plus aucun poste en cours
Historique de carrière de Thomas Biancardi
Anciens postes connus de Thomas Biancardi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
| IVERIC BIO, INC. | Directeur des opérations | 01/09/2007 | 31/01/2012 |
| Investor Relations Contact | 29/08/2013 | 14/01/2015 | |
| Public Communications Contact | 01/09/2007 | - | |
| Corporate Officer/Principal | 19/08/2013 | - | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Directeur des opérations | - | - |
| Directeur Financier/CFO | - | - |
Formation de Thomas Biancardi
| New York University | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Bourse
- Insiders
- Thomas Biancardi
- Expérience
